Search - tctmd.com

Displaying 261 - 280 of 415

Sort: Relevancy | Date

Small Study Lends Further Support to the Anti-arrhythmic Potential of Renal Denervation

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

June 06, 2019

Bariatric Surgery Tied to Less A-fib Recurrence After Ablation

News Conference News HRS 2019

Bariatric Surgery Tied to Less A-fib Recurrence After Ablation

May 17, 2019

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

News Conference News HRS 2019

Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib

May 17, 2019

More Complications Seen at Lower-Volume A-fib Ablation Centers

News Conference News HRS 2019

More Complications Seen at Lower-Volume A-fib Ablation Centers

May 16, 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

May 10, 2019

HRS Urges Members to Get Aboard the Digital Health Train

News Conference News HRS 2019

HRS Urges Members to Get Aboard the Digital Health Train

May 10, 2019

CABANA Results Largely Generalizable to Real-World A-fib Patients

News Daily News

CABANA Results Largely Generalizable to Real-World A-fib Patients

May 03, 2019

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

April 16, 2019

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

News Conference News EHRA 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

March 26, 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

March 25, 2019

Tentative Link Found Between Solar Storms, New-Onset A-fib

News Conference News EHRA 2019

Tentative Link Found Between Solar Storms, New-Onset A-fib

March 20, 2019

Survey Says . . . Patients Like NOACs Better Than Warfarin

News Conference News EHRA 2019

Survey Says . . . Patients Like NOACs Better Than Warfarin

March 17, 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

March 17, 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

News Conference News ACC 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

Yael L. Maxwell

March 16, 2019

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

News Daily News

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

March 15, 2019

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

March 12, 2019

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

News Daily News

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

March 08, 2019

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

News Daily News

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

February 25, 2019

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

News Conference News ISC 2019

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

February 13, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.